Light-Responsive Delivery Nanoplatforms in Cancer Theranostics

Atul Garkal, Anam Sami, Jahanvi Patel, Lajja Patel, Namdev L. Dhas, Tejal Mehta

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer is the second leading cause of death worldwide, accounting for a predictable 9.6 million patient losses, or one in six deaths. In men, lung, liver, colorectal, prostate, and stomach cancer are the most common types of cancer, while in women, breast, lung, colorectal, thyroid, and cervical cancer are the most common. In recent eras, stimuli-responsive drug delivery systems play an important role in the diagnosis and treatment of these diseases. Light-responsive therapeutics have been developed as potential therapies for disease management. Photo-triggered formulations in combination with chemotherapy will be promising in the future for cancer treatment, and some of the formulations have already reached clinical trials. This chapter summarizes the different light-sensitive therapies for cancer diagnosis and treatment and their applications with mechanisms.

Original languageEnglish
Title of host publicationSite-specific Cancer Nanotheranostics
Subtitle of host publicationA Microenvironment-responsive Approach
PublisherCRC Press/Balkema
Pages155-169
Number of pages15
ISBN (Electronic)9781000960051
ISBN (Print)9781032434827
DOIs
Publication statusPublished - 01-01-2023

All Science Journal Classification (ASJC) codes

  • General Engineering
  • General Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Light-Responsive Delivery Nanoplatforms in Cancer Theranostics'. Together they form a unique fingerprint.

Cite this